OPEN allows patients to live without the ongoing burden of irritating allergies. Allergic rhinitis stands as the 3rd leading chronic disease among Americans under age 45, but only 5% of patients follow through with prescribed immunotherapy.
OPEN offers a personalized, at-home immunotherapy program using oral drops. Our approach maximizes doctors’ impact while providing top-quality allergy care that is more convenient, less expensive, and ideally safer than other options. Visit their website
![](https://pci.upenn.edu/wp-content/uploads/2021/05/OPEN-Labs-team-photo.jpg)